ForewordPreamble

Principles

Guideline 1: Commitment to the general principlesGuideline 2: Professional ethicsGuideline 3: Organisational responsibility of heads of research institutionsGuideline 4: Responsibility of the heads of research work unitsGuideline 5: Dimensions of performance and assessment criteriaGuideline 6: Ombudspersons

Research Process

Guideline 7: Cross-phase quality assuranceGuideline 8: Stakeholders, responsibilities and rolesGuideline 9: Research design

 

Guideline 10: Legal and ethical frameworks, usage rightsGuideline 11: Methods and standardsGuideline 12: DocumentationGuideline 13: Providing public access to research resultsGuideline 14: AuthorshipGuideline 15: Publication mediumGuideline 16: Confidentiality and neutrality of review processes and discussionsGuideline 17: Archiving

Non-Compliance with Good Research Practice, Procedures

Guideline 18: Complainants and respondentsGuideline 19: Procedures in cases of alleged research misconductImplementation of the Guidelines
ForewordPreamblePrinzipienGuideline 1: Commitment to the general principlesGuideline 2: Professional ethicsGuideline 3: Organisational responsibility of heads of research institutionsGuideline 4: Responsibility of the heads of research work unitsGuideline 5: Dimensions of performance and assessment criteriaGuideline 6: OmbudspersonsForschungsprozessGuideline 7: Cross-phase quality assuranceGuideline 8: Stakeholders, responsibilities and rolesGuideline 9: Research designGuideline 10: Legal and ethical frameworks, usage rightsGuideline 11: Methods and standardsGuideline 12: DocumentationGuideline 13: Providing public access to research resultsGuideline 14: AuthorshipGuideline 15: Publication mediumGuideline 16: Confidentiality and neutrality of review processes and discussionsGuideline 17: ArchivingNichtbeachtung guter wissenschaftlicher Praxis, VerfahrenGuideline 18: Complainants and respondentsGuideline 19: Procedures in cases of alleged research misconductImplementation of the Guidelines
Keyword Index
Back to last page
| Print

Keyword index

6 results for the keyword "infrastructures"

Reusable and open methods and protocols in the life sciences

19.03.2025 – Recommendations for detailed recording of research methods

Comment on: GL11 (Life sciences) , GL12 (Life sciences) , GL13 (Life sciences)

Utilisation of existing data sets in medicine/the life sciences

30.09.2024 – Both the secondary utilisation of collected research data and the use of routine data are essential components of compatible and resource-saving research practice. Access to the data is a fundamental requirement, but it is equally important for ...

Comment on: GL9 (Life sciences) , GL10 (Life sciences) , GL11 (Life sciences)

Enhancing reproducible research practices

15.08.2024 – The reproducibility or replicability of results is a fundamental quality criterion in many areas of research. In order to make scientific studies or experiments reproducible or replicable, Guideline 12 requires transparent information to be provided so ...

Comment on: GL2 (General) , GL3 (General) , GL4 (General) , GL7 (General)

Open Science as Part of Research Culture. Positioning of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)

19.06.2023 – In its position paper entitled “Open Science as Part of Research Culture”, the DFG sets out its existing positions on the issue of open science and examines the potential and challenges involved. From the DFG’s point of view, while open science – ...

Comment on: GL7 (Statements) , GL13 (Statements)

Organisational responsibility in the management of scientific institutions in the life sciences

03.12.2020 – Organisational responsibility in the management of scientific institutions

Comment on: GL3 (Life sciences)

Archiving in the life sciences

03.12.2020 – Information and research data that is important to understanding the published results should ideally be archived for at least ten years for the purpose of verifiability. In some cases, it may be more expedient to hold the central samples for re-analysis ...

Comment on: GL17 (Life sciences)

|